Short Interest in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Grows By 34.1%

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the target of a large growth in short interest during the month of February. As of February 13th, there was short interest totaling 4,809 shares, a growth of 34.1% from the January 29th total of 3,586 shares. Approximately 3.2% of the company’s shares are short sold. Based on an average daily volume of 620 shares, the short-interest ratio is presently 7.8 days. Based on an average daily volume of 620 shares, the short-interest ratio is presently 7.8 days. Approximately 3.2% of the company’s shares are short sold.

iShares Neuroscience and Healthcare ETF Stock Up 0.5%

Shares of IBRN traded up $0.14 during mid-day trading on Wednesday, hitting $31.12. 447 shares of the company’s stock traded hands, compared to its average volume of 2,118. The firm has a market capitalization of $4.67 million, a P/E ratio of 15.61 and a beta of 0.93. The business’s 50-day moving average price is $32.29 and its 200-day moving average price is $29.76. iShares Neuroscience and Healthcare ETF has a 1 year low of $17.86 and a 1 year high of $37.00.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.